A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)

Completed · Phase 3 · Has a placebo group

Conditions studied: Autism

In brief

The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism in children with all levels of fecal chymotrypsin.

Key facts

Study ID
NCT02410902
Run by
Curemark
People needed
190
Starts
2015-05-13
Expected to finish
2017-12-22
Last updated by the study team
2023-05-24

Who can join

Age: 3 and older, up to 8. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.